Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
37
Number of overlapping holdings
9.5%
% of VHT's 417 holdings also in XPH
90.2%
% of XPH's 41 holdings also in VHT
Overlap by Weight
Sector Drift (VHT minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in VHT |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 4.9% | 3.7% | 3.7% |
|
ELI LILLY & CO | 11.0% | 3.7% | 3.7% |
|
MERCK & CO. INC. | 3.6% | 3.5% | 3.5% |
|
PFIZER INC | 2.4% | 3.6% | 2.4% |
|
BRISTOL-MYERS SQUIBB CO | 2.0% | 3.7% | 2.0% |
Position Highlights (Non-Overlapping Exposures)
VHT Overweight Relative to XPH
|
UNITEDHEALTH GROUP INC | 7.9% |
|
ELI LILLY & CO | 7.3% |
|
ABBVIE INC | 5.4% |
|
ABBOTT LABORATORIES | 3.8% |
|
THERMO FISHER SCIENTIFIC INC | 3.2% |
|
INTUITIVE SURGICAL INC | 2.9% |
|
AMGEN INC | 2.7% |
|
BOSTON SCIENTIFIC CORP | 2.4% |
|
GILEAD SCIENCES INC | 2.3% |
|
DANAHER CORP | 2.2% |
VHT Underweight Relative to XPH
|
TARSUS PHARMACEUTICALS, INC. | -3.8% |
 |
PERRIGO CO | -3.7% |
|
ELANCO ANIMAL HEALTH, INC. | -3.6% |
|
AXSOME THERAPEUTICS, INC. | -3.6% |
|
CORCEPT THERAPEUTICS INC | -3.6% |
|
ORGANON & CO. | -3.5% |
|
PRESTIGE BRANDS HOLDINGS INC | -3.5% |
|
INTRA-CELLULAR THERAPIES INC | -3.5% |
|
ROYALTY PHARMA PLC CLASS A | -3.3% |
|
VIATRIS, INC. | -3.3% |